Karolin Trautmann (Karolin Trautmann-Grill)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Hodgkin Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (6) (2022)
Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (6) (2022)
Joerg Haier, Johannes Beller, Kristina Adorjan, Stefan Bleich, Moritz de Greck, Frank Griesinger, Markus Vincent Heppt, René Hurlemann, Soeren Torge Mees, Alexandra Philipsen, Gernot Rohde, Georgia Schilling, Karolin Trautmann, Stephanie E Combs, Siegfried Geyer, Juergen Schaefers
Differences in Stakeholders' Perception of the Impact of COVID-19 on Clinical Care and Decision-Making. Cancers 14 (17) (2022)
Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)